Mounteney J - Search Results

1

Fentanils: a serious threat to public health.

Mounteney J, Griffiths P, Sedefov R, Evans-Brown M. Mounteney J, et al. Addiction. 2019 May;114(5):783-785. doi: 10.1111/add.14542. Epub 2019 Jan 18. Addiction. 2019. PMID: 30659693 No abstract available.

2

Challenges of reliability and validity in the identification and monitoring of emerging drug trends.

Mounteney J, Fry C, McKeganey N, Haugland S. Mounteney J, et al. Subst Use Misuse. 2010;45(1-2):266-87. doi: 10.3109/10826080903368598. Subst Use Misuse. 2010. PMID: 20025453

3

Truancy, alcohol use and alcohol-related problems in secondary school pupils in Norway.

Mounteney J, Haugland S, Skutle A. Mounteney J, et al. Health Educ Res. 2010 Dec;25(6):945-54. doi: 10.1093/her/cyq044. Epub 2010 Sep 9. Health Educ Res. 2010. PMID: 20829296

4

Earlier warning: a multi-indicator approach to monitoring trends in the illicit use of medicines.

Mounteney J, Haugland S. Mounteney J, et al. Int J Drug Policy. 2009 Mar;20(2):161-9. doi: 10.1016/j.drugpo.2007.09.006. Epub 2007 Nov 26. Int J Drug Policy. 2009. PMID: 18032012

5

Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?

Griffiths P, Vingoe L, Hunt N, Mounteney J, Hartnoll R. Griffiths P, et al. Among authors: mounteney j. Subst Use Misuse. 2000 May-Jun;35(6-8):811-44. doi: 10.3109/10826080009148423. Subst Use Misuse. 2000. PMID: 10847213 Review.

6

Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Griffiths P, Mounteney J, Lopez D, Zobel F, Götz W. Griffiths P, et al. Among authors: mounteney j. Addiction. 2012 Feb;107(2):254-8. doi: 10.1111/j.1360-0443.2011.03369.x. Epub 2011 May 3. Addiction. 2012. PMID: 21539630

7

Reducing drug related mortality in Europe - a seemingly intractable public health issue.

Giraudon I, Vicente J, Matias J, Mounteney J, Griffiths P. Giraudon I, et al. Among authors: mounteney j. Adicciones. 2012;24(1):3-7. Adicciones. 2012. PMID: 22508011

8

Understanding changes in heroin availability in Europe over time: emerging evidence for a slide, a squeeze and a shock.

Griffiths P, Mounteney J, Laniel L. Griffiths P, et al. Among authors: mounteney j. Addiction. 2012 Sep;107(9):1539-40. doi: 10.1111/j.1360-0443.2012.03829.x. Epub 2012 Apr 17. Addiction. 2012. PMID: 22509981 No abstract available.

9

Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe.

Mounteney J, Giraudon I, Denissov G, Griffiths P. Mounteney J, et al. Int J Drug Policy. 2015 Jul;26(7):626-31. doi: 10.1016/j.drugpo.2015.04.003. Epub 2015 Apr 17. Int J Drug Policy. 2015. PMID: 25976511

10

The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.

Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. Mounteney J, et al. Addiction. 2016 Jan;111(1):34-48. doi: 10.1111/add.13056. Epub 2015 Sep 30. Addiction. 2016. PMID: 26419329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results